COMMUNIQUÉS West-GlobeNewswire

Sienna Announces December Dividend

14/12/2018 - 17:31

MARKHAM, Ontario, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) for [...]

Diamond CBD, POTN Subsidiary Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules

14/12/2018 - 15:54

Launching This New CBD-Infused Coffee Line, Company Brings Homes and Offices Nationwide an Enhanced and Chill Coffee Drinking Experience MIAMI, Fla., Dec. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc [...]

GOLDLINE CBD Brand 40% Off Site-Wide in Celebration of the 2018 Farm Bill

14/12/2018 - 15:00

FORT LAUDERDALE, FL, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- VPR Brands, LP (OTC PINK: VPRB ), a market leader in innovation specializing in accessories and vaporizers for cannabis concentrates and [...]

Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares

14/12/2018 - 15:00

BASEL, Switzerland, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXON) ("Axovant") today announced the pricing of its underwritten public offering of 30,000,000 of its common shares at a price to the [...]

ALK upgrades its full-year financial outlook due to accelerated sales

14/12/2018 - 14:33

ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that the company has revised its 2018 financial guidance upwards based on an expected strong end to the year which further builds on the momentum established [...]

IBEX Reports Results for the First Quarter Ended October 31, 2018

14/12/2018 - 14:00

MONTRÉAL, Dec. 14, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the three months ended October 31, 2018. “As expected, revenues in [...]

Director/PDMR Shareholding

14/12/2018 - 14:00

Director/PDMR Shareholding December 14, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging [...]

Profound Medical Announces Changes to Commercial Organization

14/12/2018 - 14:00

TORONTO, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Sport Endurance Engages INFOR Financial as Financial Advisor

14/12/2018 - 14:00

BROOKLYN, N.Y., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), announced today that it has retained INFOR Financial Inc. (“INFOR Financial”) to provide financial advisory services [...]

WishBone Medical, Inc. signs licensing agreement for the Guided Growth Plate

14/12/2018 - 14:00

WARSAW, Ind., Dec. 14, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. has been granted a global, non-exclusive license for the sale of a patented guided growth plating system in children with deformed limbs. These 3 [...]

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency

14/12/2018 - 13:30

BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients [...]

Radient Technologies Inc. Ready to Serve $22B U.S. Market for Hemp-Derived CBD

14/12/2018 - 13:30

EDMONTON, Alberta, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is encouraged by the approval by the U.S. Senate and House of Representatives of the 2018 [...]

Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO

14/12/2018 - 13:00

Rimiducid-activated GoCAR-T ® resulted in significant expansion and persistence of T cells Initial evidence of biologic activity and stable disease observed in some patients with single rimiducid dose BPX-601 was well- [...]

Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment

14/12/2018 - 13:00

- 32.4% of patients evaluable for efficacy achieved partial response or better; 76.5% of patients achieved disease control - - Tumor shrinkage observed in both injected and uninjected lesions, indicating an abscopal [...]

iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction

14/12/2018 - 12:15

BEIJING, Dec. 14, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

The Finnish Competition and Consumer Authority has given the final approval for the transaction between Terveystalo and Attendo which is intended to be completed on 28 December 2018

14/12/2018 - 12:01

Terveystalo Plc Stock exchange release 14 December 2018 at 13:00 EET Terveystalo signed an agreement on 17 May 2018 to acquire the Finnish healthcare operations of Attendo AB. The Finnish Competition and Consumer [...]

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0475 Per Share

14/12/2018 - 12:00

MISSION VIEJO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]

Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license

14/12/2018 - 10:21

Pratteln, Switzerland, December 14, 2018 - Santhera Pharmaceuticals Holding AG (SIX: SANN) has completed its ordinary capital increase with the placement of 3,133,334 new shares by way of an accelerated bookbuilding and [...]

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

14/12/2018 - 09:22

Company announcement – No. 31 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, December 14, 2018 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a [...]